Phase II, open-label, randomized study of first-line zolbetuximab plus gemcitabine and nab-paclitaxel (GN) in Claudin 18.2–positive metastatic pancreatic cancer (mPC). Wungki Park , Eileen Mary ...

Automated Code-based Test Selection for Software Product Line Regression Testing Abstract: This extended abstract describes the Journal First summary of our article with the same title published in ...

This valuable study identifies asymmetric dimethylarginine (ADMA) histones as potential determinants of the initial genomic binding of Rhino, a Drosophila-specific chromatin protein essential for ...